Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Perpetua Resources CORP. (OTC:PPTA) Chief Executive Officer Jonathan Cherry sold 4,079 common shares on April 2, 2026, for about $119,555. The sale - executed at prices between $29.28 and $29.44 - was reported on a Form 4 and reflects shares sold to meet tax withholding obligations tied to Restricted Share Units that vested February 21, 2026 and we…
CoreWeave Chief Strategy Officer and company director Brian M. Venturo sold 65,005 Class A shares on March 31, 2026, for $4,813,620, and simultaneously exercised options and converted 126,752 restricted stock units into shares. The stock has risen since the sale but remains down materially over six months. Separately, CoreWeave reported strong MLPe…
CoreWeave General Counsel and Secretary Kristen J McVeety reported a sale of 11 shares of Class A common stock for $814 on March 31, 2026. The transaction coincides with company announcements covering MLPerf Inference v6.0 benchmark performance and the closing of an $8.5 billion delayed draw term loan facility. Analysts' commentary and recent ratin…
CoreWeave Principal Accounting Officer Jeff Baker sold 16 shares of Class A common stock on March 31, 2026, for $74.05 per share, totaling $1,184. The transaction followed the conversion of 30 restricted stock units into Class A shares. The stock has since traded as high as $82.25 but remains down 39% over six months. Separately, CoreWeave reported…
CoreWeave Chief Development Officer Brannin McBee sold 56,031 shares of Class A common stock on March 31, 2026, at $74.05 per share for about $4.15 million, while exercising options to acquire 121,099 shares the same day. The sale was disclosed on a Form 4 as a transaction linked to covering tax obligations arising from the vesting and settlement o…
CoreWeave CEO Michael N. Intrator sold 77,939 Class A shares on March 31, 2026, for about $5.77 million and exercised options to acquire an additional 140,338 shares. The company reported strong MLPerf inference results for its Nvidia GB200 and GB300 systems and closed an $8.5 billion delayed draw term loan facility that was oversubscribed. Multipl…
CoreWeave EVP of Product & Engineering Goldberg Chen sold 16 shares of Class A common stock on March 31, 2026, for $74.05 a share, totaling $1,184, to satisfy tax obligations tied to vested restricted stock units. The same day Chen received 30 Class A shares upon RSU settlement. Separately, CoreWeave reported strong MLPerf Inference v6.0 results us…
Michelle Bushore, Executive Vice President and Chief Legal Officer of Realty Income (NASDAQ: O), sold 7,400 shares on April 2, 2026, for roughly $461,908. The sale, disclosed in a Form 4 filing with the SEC, followed a period in which Realty Income priced an $800 million senior unsecured note offering, executed a $500 million cross-currency swap, a…
Daniel C. Keith, a director of Sinclair, Inc. (NASDAQ: SBGI), sold 41,990 shares of Class A Common Stock in three transactions from March 31 to April 2, 2026, realizing about $550,323. After the sales, Keith indirectly holds 25,027 Class A shares through a family trust. The trades come while SBGI shares trade around $13.01, and follow a fourth-quar…
Chris K. Visser, Zumiez Inc.'s Chief Legal Officer and Secretary, sold 9,974 shares of common stock on April 1, 2026, at $22.2139 per share, generating about $221,561. After the sale, Visser holds 43,500 shares. Separately, Zumiez reported fourth-quarter fiscal 2025 results that produced an EPS of $0.78 versus analyst expectations of $1.08, a 27.78…
Bloom Energy Chief Commercial Officer Aman Joshi sold 10,000 Class A shares on April 1, 2026, for $1.35 million under a pre-arranged Rule 10b5-1 trading plan. The company reported 2025 results above its targets, announced a new CFO and received mixed analyst reactions on price targets and ratings. InvestingPro data notes a 601% one-year share price…
22NW Fund, LP executed two sales of L.B. Foster Company (NASDAQ:FSTR) common stock on March 31 and April 1, 2026, disposing of 39,931 shares for roughly $1.11 million. The filings show specific per-share prices, post-transaction holdings, and a joint Form 4 filed by several related entities. These stock sales occur while the company reported mixed …
Kodiak Sciences Inc. Chief Financial Officer John A. Borgeson sold 29,900 shares on April 2, 2026, in transactions totaling $1,197,488, while also exercising options to acquire 30,000 shares. The trades were executed under a 10b5-1 plan and occurred as the stock traded close to its 52-week high after strong clinical readouts for retinal therapies p…
Todd M. DuChene, Core Scientific's Chief Legal and Administrative Officer, sold 10,000 shares of the company's common stock on April 1, 2026, generating $152,523. The transaction followed a March 31, 2026 vesting of performance-based restricted stock units and tax-withholding related to that vesting. The company has also expanded its funded commitm…
Grid Dynamics Holdings Inc. (GDYN) Chief Operating Officer Yury Gryzlov sold 1,245 shares on April 2, 2026, under a Rule 10b5-1 plan, netting $6,897. The transaction was disclosed on a Form 4 filing with the SEC. The stock is trading close to its 52-week low and has fallen 59% over the last year. Separately, Grid Dynamics reported fourth-quarter 20…
Adam Crystal, President of Research & Development at Tango Therapeutics (NASDAQ: TNGX), sold 27,000 shares on April 1, 2026, in transactions tied to a pre-established Rule 10b5-1 plan. The sale followed the exercise of stock options and leaves Crystal with 112,622 shares. The company reported sizable 2025 losses, while several analysts reiterated o…
Hinge Health Executive Chairman and Co-Founder Gabriel M.I. Mecklenburg sold 50,000 shares of Class A Common Stock on April 1, 2026, in two tranches for roughly $1.9 million and converted 50,000 Class B shares to Class A that same day. The transaction occurred as the company, valued at $3.03 billion, traded near $38.98, and amid a slate of analyst …
Remitly Global Chief Business Officer Pankaj Sharma sold 10,000 shares on April 1, 2026, for about $152,600 and exercised options to buy 10,000 shares the same day. The company delivered quarterly revenue and adjusted EBITDA ahead of expectations and issued first-quarter fiscal 2026 guidance while updating its leadership team.
Klaviyo Co-CEO and director Andrew Bialecki sold 200,000 shares of Series A common stock on March 31, 2026, generating $3.88 million, and converted 200,000 Series B shares into Series A that same day. The transactions, executed under a Rule 10b5-1 plan adopted May 20, 2025, occur as Klaviyo announces a $500 million repurchase program that includes …
Walter Timothy Winn, Co-COO and EVP of Southland Holdings, Inc. (NASDAQ:SLND), bought 29,177 shares on March 31, 2026, in a transaction worth $42,890. The purchase occurred as the company contends with a large fourth-quarter loss for 2025 and a legal settlement tied to a major convention center expansion project. InvestingPro analysis flags SLND as…
Airgain Inc. President and CEO Suen Jacob sold 1,000 shares on April 1, 2026, under a Rule 10b5-1 plan, netting $5,510. The company reported Q4 2025 results that missed analyst expectations while disclosing new commercial wins and a strategic partnership aimed at expanding 4G and 5G coverage. Shares are trading near their assessed Fair Value and th…
Ionis Pharmaceuticals director Joseph Klein III executed sales of 22,321 shares on April 1, 2026, totaling about $1.69 million, while also exercising options that converted to 22,321 shares with an aggregate value of $880,706. The company simultaneously disclosed new wholesale pricing for Tryngolza and multiple firms adjusted or reaffirmed analyst …
Rubrik director John Wendell Thompson sold 13,500 Class A shares on April 1, 2026, for about $660,331 under a Rule 10b5-1 trading plan, including the conversion of 11,000 Class B shares to Class A. The company's stock has fallen 39% over six months even as Rubrik reported quarterly results and an outlook that topped FactSet consensus and launched s…
Shannon L. Devers, Executive Vice President and Chief Human Resources Officer at Ionis Pharmaceuticals (IONS), disposed of 6,193 shares on April 2, 2026 under a Rule 10b5-1 plan, netting $458,613 at a weighted average price of $74.0535. The transaction coincides with a new wholesale acquisition cost for Tryngolza that exceeds earlier guidance and h…
Reddit Chief Executive Officer Steve Huffman sold 14,697 shares of Class A common stock on March 31, 2026, realizing roughly $2.39 million in proceeds. The sales followed an option exercise that added 18,000 shares at $25.29 per share. The transactions took place under a Rule 10b5-1 plan adopted in May 2025. Reddit recently reported strong fourth-q…
